These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26828283)

  • 1. Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles.
    Bartoş A; Bartoş D; Szabo B; Breazu C; Opincariu I; Mironiuc A; Iancu C
    Drug Metab Rev; 2016; 48(1):27-46. PubMed ID: 26828283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
    Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
    Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
    Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for Colorectal Cancer Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives.
    Dong Z; Cui MY; Peng Z; Li Y; Wang X; Fang Z; Jiang M; Xu L; Luo Y; Li ZP; Feng ST
    Curr Cancer Drug Targets; 2016; 16(6):536-50. PubMed ID: 26632434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle therapeutics for prostate cancer treatment.
    Sanna V; Sechi M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered nanoparticles for drug delivery in cancer therapy.
    Sun T; Zhang YS; Pang B; Hyun DC; Yang M; Xia Y
    Angew Chem Int Ed Engl; 2014 Nov; 53(46):12320-64. PubMed ID: 25294565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
    Prados J; Melguizo C; Perazzoli G; Cabeza L; Carrasco E; Oliver J; Jiménez-Luna C; Leiva MC; Ortiz R; Álvarez PJ; Aranega A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):21-34. PubMed ID: 23676104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Getting into the colon: approaches to target colorectal cancer.
    Patel MM
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1343-50. PubMed ID: 24898947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
    Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles: Attractive tools to treat colorectal cancer.
    Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer.
    Zhang J; Ali K; Wang J
    Int J Nanomedicine; 2024; 19():6693-6715. PubMed ID: 38979534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
    Chen H; Zhao Y; Wang H; Nie G; Nan K
    Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
    Anchordoquy TJ; Barenholz Y; Boraschi D; Chorny M; Decuzzi P; Dobrovolskaia MA; Farhangrazi ZS; Farrell D; Gabizon A; Ghandehari H; Godin B; La-Beck NM; Ljubimova J; Moghimi SM; Pagliaro L; Park JH; Peer D; Ruoslahti E; Serkova NJ; Simberg D
    ACS Nano; 2017 Jan; 11(1):12-18. PubMed ID: 28068099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
    Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
    Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on nanoparticle-based contrast agents in medical imaging.
    Naseri N; Ajorlou E; Asghari F; Pilehvar-Soltanahmadi Y
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1111-1121. PubMed ID: 28933183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.